Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2018

Oct 05, 2018

SELL
$161.01 - $180.57 $367,102 - $411,699
-2,280 Closed
0 $0
Q1 2018

Apr 11, 2018

SELL
$135.59 - $157.16 $20,338 - $23,574
-150 Reduced 6.17%
2,280 $344,000
Q4 2017

Jan 10, 2018

SELL
$131.06 - $150.39 $131,060 - $150,390
-1,000 Reduced 29.15%
2,430 $327,000
Q3 2017

Oct 11, 2017

BUY
$142.62 - $155.6 $489,186 - $533,708
3,430
3,430 $502,000

Others Institutions Holding JAZZ

About Jazz Pharmaceuticals plc


  • Ticker JAZZ
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,680,700
  • Market Cap $7.94B
  • Description
  • Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...
More about JAZZ
Track This Portfolio

Track Franklin Street Advisors Inc Portfolio

Follow Franklin Street Advisors Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Franklin Street Advisors Inc , based on Form 13F filings with the SEC.

News

Stay updated on Franklin Street Advisors Inc with notifications on news.